Frontiers in Drug Safety and Regulation | Cardiovascular Drug Safety

Specialty Chief Editor

marco tuccori

University of Pisa

Pisa, Italy

Specialty Chief Editor

Cardiovascular Drug Safety

Associate Editors

ole ahlehoff

Department of Cardiology, Rigshospitalet, University of Copenhagen

Copenhagen, Denmark

Associate Editor

Cardiovascular Drug Safety

giuseppe ando'

University of Messina

Messina, Italy

Associate Editor

Cardiovascular Drug Safety

andrea burden

ETH Zürich

Zurich, Switzerland

Associate Editor

Cardiovascular Drug Safety

macarius donneyong

The Ohio State University

Columbus, United States

Associate Editor

Cardiovascular Drug Safety

igor diemberger

University of Bologna

Bologna, Italy

Associate Editor

Cardiovascular Drug Safety

sergio r gutierrez-ureña

Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara

Guadalajara Jalisco, Mexico

Associate Editor

Cardiovascular Drug Safety

miroslav harjaček

United Arab Emirates University

Al-Ain, United Arab Emirates

Associate Editor

Cardiovascular Drug Safety

ke huang

North Carolina State University

Raleigh, United States

Associate Editor

Cardiovascular Drug Safety

meghna jani

The University of Manchester

Manchester, United Kingdom

Associate Editor

Cardiovascular Drug Safety

luis j jara

National Autonomous University of Mexico

México City, Mexico

Associate Editor

Cardiovascular Drug Safety

rik joos

Ziekenhuisnetwerk Antwerpen Dept Rheumatology

Antwerp, Belgium

Associate Editor

Cardiovascular Drug Safety

jose kerr saraiva

Pontifical Catholic University of Campinas

Campinas, Brazil

Associate Editor

Cardiovascular Drug Safety

hiraku kumamaru

The University of Tokyo

Bunkyo, Japan

Associate Editor

Cardiovascular Drug Safety

edward lai

National Cheng Kung University

Tainan, Taiwan

Associate Editor

Cardiovascular Drug Safety

joshua kueiyu lin

Brigham and Women's Hospital, Harvard Medical School

Boston, United States

Associate Editor

Cardiovascular Drug Safety